Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
| Data | Nome del titolare | Azioni transazionate | Intervallo di valore ($) | Tipo di transazione | Intervallo di prezzo ($) | Azioni a fine dichiarazione | % di variazione |
|---|---|---|---|---|---|---|---|
| 2026-06-15 | Mr. German LopezInsider | 200,00 | 746,87 | Acquisition Under Employee Benefit Plan | 3,73 | 15,54k | 1,30% |
| 2026-06-15 | Mr. German LopezInsider | 794,00 | 5,32k | Acquisition Under Employee Benefit Plan | 6,70 | 15,54k | 5,38% |
| 2026-06-15 | Mr. Henrique DiasGlobal VP of Marketing | 140,00 | 522,81 | Acquisition Under Employee Benefit Plan | 3,73 | 12,27k | 1,15% |
| 2026-06-15 | Mr. Arvind UtchanahCFO | 991,00 | 5,76k | Acquisition Under Employee Benefit Plan | 3,73 - 6,70 | 109,66k | 0,91% |
| 2026-06-15 | Ms. Susan Caroline EmblemGlobal VP of HR | 1,24k | 7,21k | Acquisition Under Employee Benefit Plan | 3,73 - 6,70 | 45,60k | 2,79% |
| 2026-06-15 | Ms. Amal KhouriChief Business Officer | 1,37k | 7,40k | Acquisition Under Employee Benefit Plan | 3,73 - 6,70 | 200,18k | 0,69% |
| 2026-06-15 | Mr. Jonathan Ross GoodmanExecutive Chairman | 985,00 | 5,80k | Acquisition Under Employee Benefit Plan | 3,73 - 6,70 | 21,84M | 0,00% |
| 2026-06-15 | Ms. Samira SakhiaPresident, CEO & Director | 2,65k | 15,64k | Acquisition Under Employee Benefit Plan | 3,73 - 6,70 | 448,85k | 0,59% |
| 2026-06-10 | Ms. Melanie GroleauGlobal VP of Medical & Clinical | -34,53k | 40,30k | Derivative Exercise and Sale | 5,04 - 6,64 | 10,39k | - |
| 2026-06-10 | Ms. Melanie GroleauGlobal VP of Medical & Clinical | -14,18k | 32,79k | Derivative Exercise and Sale | 4,11 - 6,64 | 10,39k | - |
| 2026-05-14 | Mr. Robert N. LandeIndependent Director | -40,00k | 244,52k | Vendita | 6,11 - 6,12 | 203,18k | -16,45% |
| 2026-04-13 | Mr. James Charles GaleIndependent Lead Director | 591,00 | 3,16k | Derivative Exercise and Retained Stock | 5,35 | 53,00k | 1,13% |
| 2026-04-10 | Mr. Michael J. TremblayIndependent Director | -20,00k | 2,75k | Derivative Exercise and Sale | 5,34 - 5,48 | 2,00k | - |
| 2026-04-06 | Mr. Robert N. LandeIndependent Director | -20,00k | 3,74k | Derivative Exercise and Sale | 5,31 - 5,50 | 243,18k | - |
| 2026-03-23 | Mr. Henrique DiasGlobal VP of Marketing | -7,73k | 36,84k | Vendita | 4,76 | 12,13k | -38,93% |
| 2026-03-26 | Cristiane Zanqueta Coelho PeevInsider | -9,88k | 50,57k | Vendita | 5,12 | 9,72k | -50,39% |
| 2026-03-23 | Mr. Henrique DiasGlobal VP of Marketing | -3,82k | 2,28k | Derivative Exercise and Sale | 4,17 - 4,76 | 12,13k | - |
| 2026-03-23 | Cristiane Zanqueta Coelho PeevInsider | 7,67k | 35,80k | Derivative Exercise and Retained Stock | 4,67 | 14,66k | 109,64% |
| 2026-03-23 | Luz Tatiana Urrea FrancoInsider | 8,77k | 40,94k | Derivative Exercise and Retained Stock | 4,67 | 8,77k | - |
| 2026-03-23 | Mr. German LopezInsider | 7,52k | 35,12k | Derivative Exercise and Retained Stock | 4,67 | 14,55k | 107,06% |
| 2026-03-23 | Ms. Melanie GroleauGlobal VP of Medical & Clinical | 4,59k | 21,42k | Derivative Exercise and Retained Stock | 4,67 | 10,39k | 79,03% |
| 2026-03-23 | Mr. Henrique DiasGlobal VP of Marketing | 6,58k | 30,71k | Derivative Exercise and Retained Stock | 4,67 | 12,13k | 118,38% |
| 2026-03-23 | Ms. Susan Caroline EmblemGlobal VP of HR | 9,30k | 43,40k | Derivative Exercise and Retained Stock | 4,67 | 44,36k | 26,51% |
| 2026-03-23 | Mônica Barbanti-Cabral-deVasconcellos PercarioInsider | 11,39k | 53,19k | Derivative Exercise and Retained Stock | 4,67 | 21,20k | 116,09% |
| 2026-03-23 | Leopoldo Agustin BosanoInsider | 13,18k | 61,54k | Derivative Exercise and Retained Stock | 4,67 | 19,48k | 209,34% |
| 2026-03-23 | Ms. Samira SakhiaPresident, CEO & Director | 95,95k | 447,99k | Derivative Exercise and Retained Stock | 4,67 | 446,20k | 27,39% |
| 2026-03-23 | Ms. Samira SakhiaPresident, CEO & Director | 332,81k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 1,91M | 21,09% |
| 2026-03-23 | Ms. Amal KhouriChief Business Officer | 20,13k | 94,00k | Derivative Exercise and Retained Stock | 4,67 | 198,81k | 11,27% |
| 2026-03-23 | Ms. Amal KhouriChief Business Officer | 148,01k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 812,95k | 22,26% |
| 2026-03-23 | Mr. Arvind UtchanahCFO | 36,82k | 171,90k | Derivative Exercise and Retained Stock | 4,67 | 108,67k | 51,24% |
| 2026-03-23 | Mr. Arvind UtchanahCFO | 148,01k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 951,39k | 18,42% |
| 2026-03-23 | Mr. Jonathan Ross GoodmanExecutive Chairman | 123,52k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 1,07M | 13,09% |
| 2026-03-23 | Mr. Jonathan Ross GoodmanExecutive Chairman | 44,13k | 206,03k | Derivative Exercise and Retained Stock | 4,67 | 21,84M | 0,20% |
| 2026-03-19 | Ms. Samira SakhiaPresident, CEO & Director | -115,14k | 0,00 | Other Derivative Disposition | - | 1,58M | -6,80% |
| 2026-03-19 | Mr. Jonathan Ross GoodmanExecutive Chairman | -161,25k | 0,00 | Other Derivative Disposition | - | 943,37k | -14,60% |
| 2026-03-19 | Ms. Amal KhouriChief Business Officer | -71,59k | 0,00 | Other Derivative Disposition | - | 664,94k | -9,72% |
| 2026-03-19 | Mr. Arvind UtchanahCFO | -29,39k | 0,00 | Other Derivative Disposition | - | 803,38k | -3,53% |
| 2026-03-15 | Ms. Samira SakhiaPresident, CEO & Director | 3,00k | 13,11k | Acquisition Under Employee Benefit Plan | 3,86 - 4,49 | 350,25k | 0,86% |
| 2026-03-15 | Ms. Amal KhouriChief Business Officer | 1,42k | 6,11k | Acquisition Under Employee Benefit Plan | 3,86 - 4,49 | 178,68k | 0,80% |
| 2026-03-15 | Ms. Susan Caroline EmblemGlobal VP of HR | 1,42k | 6,17k | Acquisition Under Employee Benefit Plan | 3,86 - 4,49 | 35,07k | 4,21% |
| 2026-03-15 | Cristiane Zanqueta Coelho PeevInsider | 456,00 | 2,05k | Acquisition Under Employee Benefit Plan | 4,49 | 6,99k | 6,97% |
| 2026-03-15 | Mr. Henrique DiasGlobal VP of Marketing | 131,00 | 505,31 | Acquisition Under Employee Benefit Plan | 3,86 | 9,42k | 1,41% |
| 2026-03-15 | Mr. Jonathan Ross GoodmanExecutive Chairman | 1,11k | 4,86k | Acquisition Under Employee Benefit Plan | 3,86 - 4,49 | 21,79M | 0,01% |
| 2026-03-15 | Mr. Arvind UtchanahCFO | 1,30k | 5,67k | Acquisition Under Employee Benefit Plan | 3,86 - 4,49 | 71,86k | 1,84% |
| 2026-03-15 | Mr. German LopezInsider | 1,00k | 4,50k | Acquisition Under Employee Benefit Plan | 4,49 | 7,03k | 16,63% |
| 2025-12-15 | Ms. Samira SakhiaPresident, CEO & Director | 3,58k | 15,26k | Acquisition Under Employee Benefit Plan | 3,78 - 4,38 | 347,25k | 1,04% |
| 2025-12-15 | Mr. Jonathan Ross GoodmanExecutive Chairman | 1,33k | 5,67k | Acquisition Under Employee Benefit Plan | 3,78 - 4,38 | 21,79M | 0,01% |
| 2025-12-15 | Ms. Amal KhouriChief Business Officer | 1,70k | 7,11k | Acquisition Under Employee Benefit Plan | 3,78 - 4,38 | 177,25k | 0,97% |
| 2025-12-15 | Ms. Susan Caroline EmblemGlobal VP of HR | 1,69k | 7,19k | Acquisition Under Employee Benefit Plan | 3,78 - 4,38 | 33,65k | 5,29% |
| 2025-12-15 | Mr. Arvind UtchanahCFO | 1,33k | 5,66k | Acquisition Under Employee Benefit Plan | 3,78 - 4,38 | 70,56k | 1,92% |
| 2025-12-15 | Cristiane Zanqueta Coelho PeevInsider | 470,00 | 2,06k | Acquisition Under Employee Benefit Plan | 4,38 | 6,54k | 7,75% |
| 2025-12-15 | Mr. Henrique DiasGlobal VP of Marketing | 631,00 | 2,69k | Acquisition Under Employee Benefit Plan | 3,78 - 4,38 | 9,29k | 7,29% |
| 2025-12-15 | Mr. German LopezInsider | 1,04k | 4,56k | Acquisition Under Employee Benefit Plan | 4,38 | 6,02k | 20,89% |
| 2025-12-10 | Mr. Jonathan Ross GoodmanExecutive Chairman | 3,10k | 13,33k | Acquisto | 4,30 | 21,79M | 0,01% |
| 2025-09-15 | Cristiane Zanqueta Coelho PeevInsider | 868,00 | 4,02k | Acquisition Under Employee Benefit Plan | 4,63 | 6,07k | 16,69% |
| 2025-09-15 | Mr. Henrique DiasGlobal VP of Marketing | 612,00 | 2,63k | Acquisition Under Employee Benefit Plan | 3,20 - 4,63 | 8,66k | 7,60% |
| 2025-09-15 | Mr. German LopezInsider | 966,00 | 4,47k | Acquisition Under Employee Benefit Plan | 4,63 | 4,98k | 24,05% |
| 2025-09-15 | Ms. Samira SakhiaPresident, CEO & Director | 3,03k | 13,05k | Acquisition Under Employee Benefit Plan | 3,20 - 4,63 | 343,67k | 0,89% |
| 2025-09-15 | Mr. Jonathan Ross GoodmanExecutive Chairman | 1,12k | 4,84k | Acquisition Under Employee Benefit Plan | 3,20 - 4,63 | 21,79M | 0,01% |
| 2025-09-15 | Ms. Amal KhouriChief Business Officer | 1,48k | 6,08k | Acquisition Under Employee Benefit Plan | 3,20 - 4,63 | 175,56k | 0,85% |
| 2025-09-15 | Ms. Susan Caroline EmblemGlobal VP of HR | 1,44k | 6,15k | Acquisition Under Employee Benefit Plan | 3,20 - 4,63 | 31,96k | 4,71% |
| 2025-09-15 | Mr. Arvind UtchanahCFO | 2,33k | 10,36k | Acquisition Under Employee Benefit Plan | 3,20 - 4,63 | 69,23k | 3,48% |
| 2025-06-02 | Mr. Robert N. LandeIndependent Director | -20,00k | 0,00 | Other Derivative Disposition | - | 60,00k | -25,00% |
| 2025-06-02 | Mr. James Charles GaleIndependent Lead Director | -20,00k | 0,00 | Other Derivative Disposition | - | 70,00k | -22,22% |
| 2025-04-03 | Ms. Samira SakhiaPresident, CEO & Director | -117,50k | 0,00 | Other Derivative Disposition | - | 1,69M | -6,49% |
| 2025-04-03 | Mr. Jonathan Ross GoodmanExecutive Chairman | -182,48k | 0,00 | Other Derivative Disposition | - | 1,10M | -14,18% |
| 2025-04-03 | Ms. Amal KhouriChief Business Officer | -83,97k | 0,00 | Other Derivative Disposition | - | 736,54k | -10,23% |
| 2025-04-03 | Mr. Arvind UtchanahCFO | -27,99k | 0,00 | Other Derivative Disposition | - | 832,77k | -3,25% |
| 2025-03-20 | Mr. Arvind UtchanahCFO | -27,99k | 0,00 | Other Derivative Disposition | - | 672,21k | -4,00% |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Registrati con e-mail
Hai già un account? Accedi
Non hai un account? Registrati
Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.
Caratteristiche principali
Premium
